Claimed effect · Tesamorelin

Does Tesamorelin help with cognition in older adults?

C
Grade C — weak human evidence1 RCT (n=152) · effect size: small
Short answerWeak human evidence. 1 RCT (n=152): enough to be interesting, not enough to count on. Where an effect is seen it is a small effect. 20 weeks of tesamorelin improved some executive-function measures in healthy older adults and those with mild cognitive impairment. Single trial, never replicated or developed further.

What the studies show

20 weeks of tesamorelin improved some executive-function measures in healthy older adults and those with mild cognitive impairment. Single trial, never replicated or developed further.

“The intent-to-treat analysis indicated a favorable effect of GHRH on cognition (P=.03), which was comparable in adults with MCI and healthy older adults.”

Verbatim, from the abstractBaker LD, et al. Effects of growth hormone-releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults. Arch Neurol, 2012;69:1420–1429

A few small or poorly-controlled human studies. Enough to be interesting; not enough to count on. Most of what gets called “clinically proven” online lives here.

  1. 1

In context

Tesamorelin is a synthetic analogue of growth-hormone-releasing hormone, approved in the United States to reduce excess abdominal fat in people with HIV-associated lipodystrophy. In that population it cuts visceral fat by about 15% over six months, and the fat returns when treatment stops. Its use for general fat loss, muscle or anti-ageing rests on extrapolation from that specific group; there are no trials in healthy adults. It is not authorised in the EU.

Tesamorelin is approved (rx, us). Legal status differs by country — see the regulation section or the jurisdiction pages.

Questions

Is Tesamorelin proven to help with cognition in older adults?
No. The human evidence is weak (1 RCT (n=152)); LYO grades it C.
What studies are behind the grade?
20 weeks of tesamorelin improved some executive-function measures in healthy older adults and those with mild cognitive impairment. Single trial, never replicated or developed further.
Is Tesamorelin approved for this?
Tesamorelin is an approved medicine (Approved (Rx, US)); whether this particular outcome is a licensed indication is stated on the compound page's regulation section.

Other outcomes for Tesamorelin

Written and maintained by LYO Research — how pages are written and checked. Reviewed 2 September 2026. Grades count human evidence only; see how LYO grades. Not medical advice. Correct this page →